Cargando…

Intrapancreatic Accessory Spleen: Two Case Reports of a Rare Entity

Intrapancreatic accessory splenic tissue constitutes a very unusual anatomical variation. It is encountered mostly in the splenic hilum or within the pancreatic tail. Given the diagnostic difficulty in excluding a pancreatic malignancy, a distal pancreatectomy is usually performed. We herein report...

Descripción completa

Detalles Bibliográficos
Autores principales: Kykalos, Stylianos, Machairas, Nikolaos, Molmenti, Ernesto P, Sotiropoulos, Georgios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381844/
https://www.ncbi.nlm.nih.gov/pubmed/32724745
http://dx.doi.org/10.7759/cureus.8797
Descripción
Sumario:Intrapancreatic accessory splenic tissue constitutes a very unusual anatomical variation. It is encountered mostly in the splenic hilum or within the pancreatic tail. Given the diagnostic difficulty in excluding a pancreatic malignancy, a distal pancreatectomy is usually performed. We herein report two cases of intrapancreatic accessory spleen. The first patient presented with left upper quadrant abdominal pain radiating to the back, caused by a 2-cm focal lesion in the pancreatic tail. The second patient underwent a distal pancreatectomy due to a postsplenectomy symptomatic pseudocyst that could not be treated conservatively. In both cases, the histopathological examination of the specimens revealed a 2-cm accessory spleen within the pancreatic tail. Intra and peripancreatic spleens represent 10-16% of all accessory spleens, and their sizes range from a few millimeters up to 2-3 cm. CT, MRI, and nuclear scintigraphy are all useful in establishing the diagnosis. It is occasionally difficult to differentiate accessory spleens from hypervascular pancreatic neoplasms, metastatic lesions, or splenic hilar lymphadenopathy. The surgical resection of an intrapancreatic spleen is only indicated in the case of diagnostic uncertainty or spleen-related hemato-oncological conditions such as immune thrombocytopenia (ITP).